de Jong S
de Jong S
Professor of Preclinical and Translational Oncology, University Medical Center Groningen
Verified email at - Homepage
Cited by
Cited by
Patient-derived xenograft models: an emerging platform for translational cancer research
M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ...
Cancer discovery 4 (9), 998-1013, 2014
Interrogating open issues in cancer precision medicine with patient-derived xenografts
AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ...
Nature Reviews Cancer 17 (4), 254-268, 2017
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
T Eschenhagen, T Force, MS Ewer, GW De Keulenaer, TM Suter, ...
European journal of heart failure 13 (1), 1-10, 2011
Metformin: taking away the candy for cancer?
M Jalving, JA Gietema, JD Lefrandt, S de Jong, AKL Reyners, ROB Gans, ...
European journal of cancer 46 (13), 2369-2380, 2010
Increased risk of fundic gland polyps during long‐term proton pump inhibitor therapy
M Jalving, JJ Koornstra, J Wesseling, HM Boezen, S De Jong, ...
Alimentary pharmacology & therapeutics 24 (9), 1341-1348, 2006
TRAIL receptor signalling and modulation: Are we on the right TRAIL?
D Mahalingam, E Szegezdi, M Keane, S de Jong, A Samali
Cancer treatment reviews 35 (3), 280-288, 2009
Survival-related profile, pathways, and transcription factors in ovarian cancer
APG Crijns, RSN Fehrmann, S de Jong, F Gerbens, GJ Meersma, HG Klip, ...
PLoS medicine 6 (2), e1000024, 2009
Preclinical characterisation of 111In‐DTPA‐trastuzumab
MN Lub‐de Hooge, JGW Kosterink, PJ Perik, H Nijnuis, L Tran, J Bart, ...
British journal of pharmacology 143 (1), 99-106, 2004
Tissue distribution of the death ligand TRAIL and its receptors
DC Spierings, EG de Vries, E Vellenga, FA van den Heuvel, JJ Koornstra, ...
Journal of Histochemistry & Cytochemistry 52 (6), 821-831, 2004
The clinical trail of TRAIL
EW Duiker, CH Mom, S De Jong, PHB Willemse, JA Gietema, ...
European journal of cancer 42 (14), 2233-2240, 2006
Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer
B Pennarun, A Meijer, EGE de Vries, JH Kleibeuker, F Kruyt, S de Jong
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1805 (2), 123-140, 2010
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
R Koster, A Di Pietro, H Timmer-Bosscha, JH Gibcus, A Van Den Berg, ...
The Journal of clinical investigation 120 (10), 3594-3605, 2010
Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy
CMM Van Geelen, EGE de Vries, S de Jong
Drug resistance updates 7 (6), 345-358, 2004
Fas receptor‐mediated apoptosis: a clinical application?
T Timmer, EGE de Vries, S de Jong
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2002
Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic
DJA De Groot, EGE De Vries, HJM Groen, S De Jong
Critical reviews in oncology/hematology 61 (1), 52-69, 2007
Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line
S de Jong, JG Zijlstra, EGE de Vries, NH Mulder
Cancer research 50 (2), 304-309, 1990
Patient-derived xenograft models: An emerging platform for translational cancer research. Cancer Discov. 2014; 4: 998–1013. doi: 10.1158/2159-8290
M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ...
CD-14-0001.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family
K Azijli, B Weyhenmeyer, GJ Peters, S De Jong, FAE Kruyt
Cell Death & Differentiation 20 (7), 858-868, 2013
Heart failure stimulates tumor growth by circulating factors
WC Meijers, M Maglione, SJL Bakker, R Oberhuber, LM Kieneker, ...
Circulation 138 (7), 678-691, 2018
Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors
DCJ Spierings, EGE de Vries, W Timens, HJM Groen, HM Boezen, ...
Clinical Cancer Research 9 (9), 3397-3405, 2003
The system can't perform the operation now. Try again later.
Articles 1–20